Age-related hearing loss in patients taking cognitive tests may result in misdiagnoses of dementia

 

Leicestershire, UK (July 10, 2020) — The early and correct diagnosis of a cognitive impairment – such as dementia – is crucial as it allows interventions and treatments that may slow the progression of a patient’s symptoms to be quickly put in place.

However, a new study by Loughborough University researcher Dr Christian Füllgrabe further supports that age-related hearing loss can negatively affect the outcome of cognitive tests, resulting in misdiagnoses.

This is because many cognitive screening tests use auditory stimuli (presented orally by a clinician to a patient) for memory recall and people suspected of cognitive decline are typically older, and thus likely to also suffer from age-related hearing loss.
The question of the link between hearing loss and cognitive decline has been hotly debated in recent years, but the answer has been rather elusive.

Dr Füllgrabe’s latest paper further supports that hearing loss can lead to an overestimation of cognitive decline.

In his study, 56 young normal-hearing Loughborough University students with normal cognitive functions were asked to perform three memory tasks using speech stimuli that were either unmodified or modified to mimic age-related hearing loss.

Using participants without hearing impairments allowed Dr Füllgrabe to evaluate the acute effect of hearing loss during the cognitive test on test performance.

Previous studies have used participants with actual hearing impairments but Dr Füllgrabe says as those suffering hearing loss are usually older, it can be hard to determine if the results are due to hearing loss or age-related changes in cognitive processing.

Dr Füllgrabe’s study conclusively demonstrated that memory performance was significantly lower in the group with the simulated hearing loss.

He says the findings are “strong evidence that the presentation format of the cognitive test can impact on the test performance”.

It is hoped the results will raise awareness of the issue and get clinicians to consider the possible impact of age-related hearing loss when interpreting cognitive test results.

Dr Füllgrabe, who works in the School of Sport, Exercise and Health Sciences, commented: “This new publication draws attention to the abusive interpretation that poor performance on a cognitive test necessarily indicates poor cognitive ability.

“As a frequent reviewer for numerous scientific journals and an associate editor of the International Journal of Audiology, I was well placed to witness that this issue was too often ignored.

“As explicitly advocated in the paper, I hope that, in the future, researchers and clinicians alike will consider the hearing status of their participants/patients when administering cognitive tests (such as those used for dementia screening) and interpreting their results.”
Dr Füllgrabe hopes to build on this research with Professor Eef Hogervorst (School of Sport, Exercise and Health Sciences, Loughborough University) and Dr Tobias Bast (Department of Psychology, University of Nottingham).

The researchers are hoping to use the same hearing-loss-simulation approach on a frequently used dementia screening test to help refine dementia diagnostics.

 

 

 


Loughborough University, 10.07.2020 (tB).

Schlagwörter:

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…